Senti Biosciences Holdings, Inc. SNTI
0.18 USD -0.01 (-5.37%)
At closeNov 4, 2026, 4:00 AM EST
0.20 +0.02 +12.37%
Pre-market · Nov 4, 4:00 AM ET
0.1733 Day range 0.1866
0.152 52-week range 2.88
- YTD
- -82.89%
- 1 year
- -91.11%
Financial health
Altman Z-Score
-20.89 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.4×
FY 2019 5y median -0.4× FY 2025
P/S 10629×
FY 2019 5y median 18.9× FY 2025
P/B 41.8×
FY 2019 5y median 0.6× FY 2025
P/FCF -5.4×
FY 2019 5y median -0.8× FY 2025
EV/EBITDA -4.3×
FY 2019 5y median -0.9× FY 2025
EV/Sales 11195×
FY 2019 5y median 15.7× FY 2025
FCF Yield -18.7%
FY 2019 5y median -123.1% FY 2025
Profitability
Gross Margin -16431.8%
FY 2019 5y median 100.0% FY 2025
Operating Margin -289668.2%
FY 2019 5y median -1889.3% FY 2025
Net Margin -279263.6%
FY 2019 5y median -2414.6% FY 2025
ROE -1099.3%
FY 2019 5y median -106.2% FY 2025
ROIC -149.7%
FY 2019 5y median -68.2% FY 2025
ROA -119.9%
FY 2019 5y median -57.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -4.4%
FY 2019 FY 2025
EPS (diluted) 76.2%
FY 2019 FY 2025
Free Cash Flow -5.4%
FY 2019 FY 2025
Financial Health
Current Ratio 1.7×
FY 2019 5y median 4.5× FY 2025
Quick Ratio 1.7×
FY 2019 5y median 4.5× FY 2025
Debt / Equity 5.2×
FY 2019 5y median 0.6× FY 2025
Net Debt / EBITDA -0.2×
FY 2019 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31